Yancoal Australia Ltd (ASX:YAL) Reports 2024 Financials and Declares Dividend at AGM
Yancoal Australia Ltd (ASX:YAL) reports robust 2024 financial performance and declares a $687 million dividend at its Annual General Meeting.
Yancoal Australia Ltd (ASX:YAL) reports robust 2024 financial performance and declares a $687 million dividend at its Annual General Meeting.
Goodman Group (ASX:GMG) reports Q3 FY25 operational progress with $13.7bn WIP and reaffirms 9% EPS growth forecast.
Neuren Pharmaceuticals (ASX:NEU) reports a record A$166m income in 2024, driven by DAYBUE sales and initiates Phase 3 trials for NNZ-2591.
BSP Financial Group Limited (ASX:BFL) announces strong 2024 financial results with a 16% dividend increase and ongoing modernization initiatives.
Restaurant Brands New Zealand Limited (ASX:RBD) reports record FY24 sales, improved margins, and declares a special dividend for shareholders.
AFT Pharmaceuticals (ASX:AFP) reports a 6% increase in FY25 revenue, targets $300M by FY27, and declares an increased dividend.
Oceania Healthcare (ASX:OCA) reports FY25 results, highlighting financial performance and strategic initiatives for future growth.
Dicker Data (ASX:DDR) releases FY24 results showing a 2.9% revenue increase and announces a final dividend of 11.0 cps.
Brisbane Broncos Limited (ASX:BBL) announces 2024 financial results, highlighting revenue growth, increased membership, and a final dividend declaration.
WCM Global Growth Limited (ASX:WQG) declares a fully franked dividend of 1.89c per share for Q3 FY2025 and outlines a progressive dividend policy.